Savv-e Revenue and Competitors
Estimated Revenue & Valuation
- Savv-e's estimated annual revenue is currently $6.3M per year.
- Savv-e's estimated revenue per employee is $132,000
Employee Data
- Savv-e has 48 Employees.
Savv-e's People
Name | Title | Email/Phone |
---|---|---|
1 | Manager, Client Solutions | Reveal Email/Phone |
2 | Production Manager | Reveal Email/Phone |
3 | Sales & Marketing Consultant | Reveal Email/Phone |
4 | UI Designer | Reveal Email/Phone |
5 | Project Lead / Learning Designer | Reveal Email/Phone |
Savv-e Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.7M | 43 | -17% | N/A | N/A |
#2 | $175.6M | 760 | N/A | N/A | N/A |
#3 | $1.7M | 17 | N/A | N/A | N/A |
#4 | $2.4M | 21 | N/A | N/A | N/A |
#5 | $2.3M | 20 | N/A | N/A | N/A |
#6 | $2.4M | 21 | N/A | N/A | N/A |
#7 | $6.3M | 48 | N/A | N/A | N/A |
#8 | $1M | 10 | N/A | N/A | N/A |
#9 | $301M | 1303 | N/A | N/A | N/A |
#10 | $41M | 226 | N/A | N/A | N/A |
What Is Savv-e?
N/A
Total Funding
48
Number of Employees
$6.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Savv-e News
2022-04-13 - Analyzing Neovasc (NASDAQ:NVCN) & enVVeno Medical ...
... Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.
2022-04-06 - enVVeno Medical Announces New U.S. VenoValve(R) Patent
The VenoValve is currently being evaluated in leading hospitals throughout the U.S. in the ongoing SAVVE U.S pivotal trial.
2022-03-22 - enVVeno Medical Reports Fourth Quarter and Year-End 2021 ...
Successfully completed 9 VenoValve surgeries and 16 sites currently activated in the Company's SAVVE U.S. pivotal trial for the VenoValve;...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.4M | 48 | -11% | N/A |
#2 | $6.8M | 52 | 49% | N/A |
#3 | $11.9M | 52 | 16% | N/A |
#4 | $10.6M | 56 | -10% | N/A |
#5 | $5.5M | 60 | 2% | N/A |